OKYO Pharma Ltd (OKYO)

Accumulating

Strong institutional accumulation: ownership increased +6.73% quarter-over-quarter.

Data as of Q1 2026

Institutional Ownership

8.49%

QoQ Change

+6.73%

Total Value

$10.3B

Shares Outstanding

75.2M

Crowding AnalysisModerate

Holders12of 5,944

Avg: 68

Uncrowded71th percentileCrowded

Institutional Activity

Buy/Sell Ratio2x

39th percentile

6 buying3 selling

New

-2

Closed

+5.7M

Net shares

Holding Period Distribution

estimate

Median: 2 QAvg: 2 QHolders: 12

Ownership Concentration

Top 5: 98.9%Top 10: 100.0%

Woodline Partners57.2%

Maven Securities18.4%

Stonepine Capital Management,13.3%

BALYASNY ASSET MANAGEMENT L.P.9.2%

UBS Group AG0.9%

Others (7)1.1%

Loading crowding analysis...

Conviction-Weighted Ownership

Median weight: 0.00%Avg weight: 0.08%Max: 0.69%High conviction (>1%): 0

Woodline Partners

Maven Securities

Stonepine Capital Management,

BALYASNY ASSET MANAGEMENT L.P.

UBS Group AG

XTX Topco

Cerity Partners

GEODE CAPITAL MANAGEMENT,

Dauntless Investment Group,

EFG International AG

Loading conviction analysis...

Whale Moves Timeline (8 Quarters)

Biggest dollar-value position changes among top 10 holders

NEWWoodline Partners$6M3.7M shr

NEWMaven Securities$2M1.2M shr

NEWStonepine Capital Management$1M850K shr

NEWBALYASNY ASSET MANAGEMENT L.P.$942K585K shr

SOLDDauntless Investment Group$753K468K shr

SOLDDauntless Investment Group$3M2.0M shr

BOUGHTRENAISSANCE TECHNOLOGIES$200K97K shr

NEWXTX Topco$36K18K shr

NEWUBS Group AG$4K2K shr

NEWEFG International AG$2K923 shr

Loading whale moves...

Institutional Trends (8 Quarters)

Loading ownership trends...

Institutional Holders

Loading top holders...